Efficacy and safety of a novel sodium picosulfate oral tablet in a randomized controlled trial for bowel preparation

Table 1 Baseline characteristics of study participants (all randomized set), n (%)/mean ± SD

	Total (n = 215)	DWJ1609 group (n = 108)	Oral sulfate tablet group (n = 107)	P value
Age (years)	43.3 ± 10.94	42.8 ± 11.83	43.8 ± 10.00	0.5631
Age < 65 years	208 (96.74)	103 (95.37)	105 (98.13)	0.4452
Age ≥ 65 years	7 (3.26)	5 (4.63)	2 (1.87)
Sex
Men	78 (36.28)	36 (33.33)	42 (39.25)	0.3672
Women	137 (63.72)	72 (66.67)	65 (60.75)
Body mass index (kg/m2)	23.94 ± 3.1005	24.072 ± 3.1191	23.802 ± 3.0904	0.6611

¹Testing for between-group differences in continuous variables after normality assessment (two-sample t-test or Wilcoxon rank-sum test).

²Testing for between-group differences in categorical variables (χ² test or Fisher’s exact test, depending on expected cell counts).